Alison Bladh

JANUARY 21, 2025

Reduced Inflammation : Compounds like oleocanthal mimic anti-inflammatory medications, offering natural pain relief. Current Pharmaceutical Design , 17(8), pp.754768. Anti-inflammatory activity of extra virgin olive oil polyphenols: which role in the prevention and treatment of immune-mediated inflammatory diseases? Russell, A.

Diet 97

Diet Pharmaceutical Marketing Management 97

The Dermatology Digest

NOVEMBER 30, 2024

Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Similarly, Incyte and AFYX Therapeutics are developing new therapeutics for lichen planus.

Pharmaceutical 36

Pharmaceutical Safety Marketing Therapy 36

The Dermatology Digest

FEBRUARY 27, 2024

Pelage Pharmaceuticals has closed a $16.75 million Series A financing led by GV with participation from Main Street Advisors, Visionary Ventures and YK BioVentures to advance a first-in-class treatment for androgenetic alopecia and other types of alopecia including chemotherapy-induced hair loss.

Pharmaceutical 36

Pharmaceutical Treatments Hospital Clinic 36

The Dermatology Digest

NOVEMBER 6, 2024

Alicia Edwards from Howard University College of Medicine will conduct a remote project titled, “ Investigating the Prevalence of Inborn Errors of Immunity and Treatment Responses in Pediatric Alopecia Areata: A Multi-Site Study ” under the mentorship of Leslie Castelo-Soccio, MD, PhD at National Institutes of Health.

Pharmaceutical 36

Pharmaceutical Hospital Dermatology Medical 36

The Dermatology Digest

DECEMBER 30, 2024

More than 200 residents, medical students and Fellow members have committed to volunteer for MBWS outreach events at universities, hospitals, and community venues, with a planned distribution of 10,000 gift bags with tips for managing winter skin and free moisturizing products generously provided by campaign sponsor, Clinique.

Webinar 78

Webinar Education Social Media Dermatology 78

The Dermatology Digest

MARCH 10, 2025

Tildrakizumab-asmn (Ilumya, Sun Pharmaceutical Industries, Inc.) ” The safety profile was consistent with the known safety profile of tildrakizumab, and no serious adverse events related to ILUMYA treatment occurred in this clinical trial,the study showed. .” In addition, 29.4% in the placebo group.

Pharmaceutical 36

Pharmaceutical Safety Clinic Injections 36

The Dermatology Digest

APRIL 3, 2024

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. Watch Now: Nanette B. in September 2023.

Pharmaceutical 36

Pharmaceutical Sales Office Partnerships 36

The Dermatology Digest

JANUARY 29, 2024

The Centers for Medicare & Medicaid Services (CMS) has issued a permanent J-Code (J7354) for Verrica’s YCANTH, a molluscum contagiosum treatment. Medicaid and Medicare patient populations,” says Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, in a news release. “In

Pharmaceutical 74

Pharmaceutical Office Medical Management 74

The Dermatology Digest

FEBRUARY 5, 2024

Children and young adults with eczema or allergies or who have difficulty swallowing may have eosinophilic esophagitis, according to a review study in the Canadian Medical Association Journal (CMAJ). Food and Drug Administration has expanded the indication for dupilumab (Dupixent, Sanofi, Regeneron Pharmaceuticals, Inc.)

Eczema 74

Eczema Pharmaceutical Management Diet 74

The Dermatology Digest

JANUARY 2, 2024

discussed treatment options, the study showed. featured the pharmaceutical industry. The researchers didn’t analyze gaps in education or melanoma information, but they noted that informational videos directed toward healthcare professionals often used medical terminology that the general population may find difficult.

Pharmaceutical 69

Pharmaceutical Education Dermatology Clinic 69

Aesthetics Advisor

FEBRUARY 11, 2024

Millions of people suffer for years or decades without treatment because insurance companies don’t approve screening for autoimmunity until the patient shows significant signs of organ or tissue destruction. At this point, the patient can be prescribed some type of immune-suppressing treatment. About the Author: Datis Kharrazian, Ph.D.,

Pharmaceutical 67

Pharmaceutical Diet Clinic Management 67

First Derm

FEBRUARY 21, 2024

There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision. A dermatologist can provide personalized recommendations and treatment plans tailored to your child’s specific needs.

Retinol 80

Retinol Social Media Skincare Routine Skincare 80

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.

Treatments 36

Treatments Pharmaceutical Dermatitis Eczema 36

The Dermatology Digest

MAY 15, 2024

Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Torii) to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH (cantharidin) for the treatment of common warts. With a prevalence of approximately 22 million patients in the U.S.

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

The Dermatology Digest

MARCH 11, 2024

Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes. Lio, MD Distraction techniques and pharmacologic measures can help keep pediatric patients comfortable during common dermatologic procedures.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

JANUARY 5, 2024

Food and Drug Administration (FDA) has approved Zelsuvmi (berdazimer topical gel, 10.3%) for the treatment of molluscum contagiosum in adults and children one year of age and older. Zelsuvmi is expected to be commercially available during the second half of 2024, according to Ligand Pharmaceuticals. in September 2023.

Pharmaceutical 36

Pharmaceutical Office Medical Dermatology 36

The Dermatology Digest

MARCH 13, 2024

Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and Health Sciences in Washington, DC, shares his excitement about chronic spontaneous urticaria (CSU) treatments coming down the pike including remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase inhibitor.

Treatments 36

Treatments Dermatitis Dermatology Eczema 36

The Dermatology Digest

OCTOBER 26, 2024

Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. Both groups had similar proportions of patients with treatment-emergent adverse events (TEAEs).

Dermatitis 36

Dermatitis Treatments Pharmaceutical Eczema 36

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Topical isotretinoin, even when applied to 90% of a patient’s body surface area, showed minimal systemic absorption.

Treatments 36

Treatments Dermatitis Eczema Dermatology 36

Lipgloss and Aftershave

SEPTEMBER 3, 2024

One of the key goals for every medical + spa skin care professional is to find procedures, products, and devices that can be used in treatment to improve and correct skin issues. Over the past year, L+A has traveled the globe looking for the most effective treatment options to share with our community. Revision Skincare, M.A.D

Chemical Peels 52

Chemical Peels Retinol Microneedling Skincare 52

AAAMS

MARCH 26, 2024

Botox and dermal fillers are powerful treatments for a wide range of aesthetic and medical conditions, but they require precise application from skilled and certified professionals. Licensed medical professionals can only purchase this controlled substance through pharmaceutical supply chains.

Injections 52

Injections Chemical Peels Training Surgery 52

AAAMS

MARCH 26, 2024

Botox and dermal fillers are powerful treatments for a wide range of aesthetic and medical conditions, but they require precise application from skilled and certified professionals. Licensed medical professionals can only purchase this controlled substance through pharmaceutical supply chains.

Injections 52

Injections Chemical Peels Training Surgery 52

Associated Skin Care Professionals

AUGUST 14, 2023

Osmosis uses a unique combination of active ingredients that focuses on three important factors: our pharmaceutical-grade delivery system, because most aging occurs deep within the skin; our patented products that create real changes in the skin; and our unique inside-out approach that triggers collagen/elastin and plumps the volume of the face.

Vitamin C 52

Vitamin C Pharmaceutical Collagen Ingredients 52

Aesthetics Advisor

AUGUST 16, 2023

a drug developer working on a treatment similar to Novo’s Wegovy, jumped 12%. better known as Weight Watchers — which bought a telemedicine firm that prescribes obesity medications earlier this year, soared 13%. Makers of syringes for the pharmaceutical industry, Stevanato Group SpA and West Pharmaceutical Services Inc.,

Sales 36

Sales Pharmaceutical Marketing Medical 36

West Lake Dermatology

OCTOBER 15, 2024

The increasing popularity of weight loss medications like semaglutide and tirzepatide highlights the effectiveness of GLP-1 receptor agonists in helping individuals manage their weight. In clinical trials, medications like semaglutide have shown substantial results. However, as with any medication, there are potential side effects.

Medical 36

Medical Management Sustainability Pharmaceutical 36

Hollywood Institute

JANUARY 2, 2023

Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceutical treatments. Physical therapists incorporate pain management strategies like trigger point massages in their treatment routines because they successfully provide patients with pain relief. What is Trigger Point Therapy?

Therapy 52

Therapy Pharmaceutical Tools Irritation 52

The Dermatology Digest

MARCH 13, 2024

Silverberg, MD, Chief of Pediatric Dermatology for the Mount Sinai Health System in New York, reviews the rationale for treating Molluscum Contagiosum and shares updates on available treatments including disruptive techniques and the newly approved Zelsuvmi (berdazimer topical gel, 10.3% (Zelsuvmi, Ligand) cantharidin (Ycanth, Verrica).

Treatments 28

Treatments Dermatitis Dermatology Eczema 28

Aesthetics Advisor

JANUARY 18, 2024

Currently there are three main categories of pharmaceutical agents used to treat or prevent ischemia issues: thrombolytics, antiplatelets, and anticoagulants. Is there not a safer and also effective natural option for helping patients besides the above categories of pharmaceuticals? 12 Coronary Artery Disease.

Pharmaceutical 36

Pharmaceutical Extractions Clinic Safety 36

The Dermatology Digest

MARCH 6, 2024

Sun Pharmaceutical Industries, Inc. Food and Drug Administration-approved topical acne treatment available in the U.S. The parents misunderstand this unfamiliar word as inappropriate for family dinner conversation but quickly learn from Dr. Lee that it is a medical term that does not need to be censored.

Sebum 36

Sebum Social Media Pharmaceutical Sales 36

The Dermatology Digest

FEBRUARY 5, 2024

“Through our innovative device and technologies, we are confident that Trufacial customers will experience the optimal at-home skincare to address their individual cosmetic concerns and maintain favorable outcomes from in-office treatments.” Perfect Corp. Expands AI Skin Simulation Technology Perfect Corp.

Dermatology 36

Dermatology Pharmaceutical Technology Sales 36

The Dermatology Digest

MARCH 8, 2024

LEO Pharma recently acquired TMB-001 and other assets from Timber Pharmaceuticals following Timber’s Chapter 11 bankruptcy filing. If and when we receive FDA approval, we will consider this treatment as a potential part of lifestyle management for CI. Will we see a focus on orphan diseases from LEO Pharma?

Pharmaceutical 36

Pharmaceutical Eczema Dermatology Innovations 36

The Dermatology Digest

FEBRUARY 26, 2024

Urticaria symptoms clear within minutes after dosing , and neffy could offer patients a novel treatment option to address existing gaps in the efficacy of currently available antihistamines or biologics.” Food and Drug Administration (FDA) opted not to approve neffy for emergency treatments of severe allergic reactions in September 2023.

Pharmaceutical 36

Pharmaceutical Hospital Clinic Medical 36

The Dermatology Digest

MARCH 11, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 15, 2024

Sun Pharmaceutical Industries, Inc. Food and Drug Administration-approved topical acne treatment available in the U.S. Food and Drug Administration-approved topical acne treatment available in the U.S. The new campaign focuses on the role of sebum as a main cause of acne. WINLEVI is the first and only U.S.

Sebum 36

Sebum Document Pharmaceutical Education 36

The Dermatology Digest

FEBRUARY 27, 2024

“The approval of SIMLANDI marks the first high-concentration, citrate-free biosimilar to Humira with IC status,” says Dr. Eric Hughes, Executive Vice President Global R&D and Chief Medical Officer at Teva, in a news release. where biologics represent well over 40% of all pharmaceutical spending.

Safety 36

Safety Marketing Pharmaceutical Partnerships 36

The Dermatology Digest

MARCH 11, 2024

Joshua Zeichner, MD, Associate Professor of Dermatology at the Mount Sinai Hospital in New York City, reviews the latest information on prescribing and monitoring isotretinoin for patients with severe nodulocystic acne and provides an update on the potential risks associated with this medication.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Del Rosso, DO, a dermatologist in Las Vegas, NV, and the new President of the American Acne and Rosacea Society.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36